ESOS: a European study on the orthopaedic status of patients with haemophilia and inhibitors.
Published studies highlight the paucity of data relating to orthopaedic health and quality of life in haemophilia patients with inhibitors. A European Study on the Orthopaedic Status of Patients with Haemophilia and Inhibitors (ESOS) has been set up to address this lack of data. This cross-sectional retrospective study aims to enrol 400 patients from 50 sites in nine European countries. The primary outcome measure of the study is the burden of orthopaedic complications in patients with severe haemophilia and inhibitors. The data that will be generated should demonstrate the high level of arthropathy in haemophilia patients with inhibitors and show the need to focus on improving orthopaedic health in this rare, but particularly vulnerable, patient population.
Dolan
G
G
University Hospital, Queen's Medical Centre, Nottingham, UK. gerry.dolan@nottingham.ac.uk
D019774:Blood Coagulation Factor Inhibitors / Q000097:blood; D005060:Europe; D006304:Health Status; D006395:Hemarthrosis / Q000209:etiology*; D006467:Hemophilia A / Q000150:complications* / Q000534:rehabilitation; D006801:Humans; D007391:International Cooperation; D008297:Male; D011788:Quality of Life
D019774:Blood Coagulation Factor Inhibitors